Notably, the use of diphenoxylate at much higher dosage for a long time would result in an opposite result, with colonic AQP3 expression downregulated in these constipation models (Zhan et al., 2020; Tan et al., 2021). The gene discussed is AQP3; the disease is constipation disorder.